(Q54296243)
Statements
Spliceosome-related gene mutations in myelodysplastic syndrome can be used as stable markers for monitoring minimal residual disease during follow-up. (English)
1 reference
Kazuyuki Matsuda
1 reference
Fumihiro Ishida
1 reference
Toshiro Ito
1 reference
Hideyuki Nakazawa
1 reference
Shuhei Miura
1 reference
Chiaki Taira
1 reference
Akane Sueki
1 reference
Yukihiro Kobayashi
1 reference
Takayuki Honda
1 reference
14 August 2012
1 reference
36
1 reference
11
1 reference
1393-1397
1 reference
Identifiers
1 reference